X-Sympa-To: patents
Return-Path: <rms@gnu.org>
Delivered-To: patents@aful.org
Received: from fencepost.gnu.org (fencepost.gnu.org [199.232.76.164])
	by stabilite.aful.org (Postfix) with ESMTP id 3FD6F42072
	for <patents@aful.org>; Sat, 26 Apr 2003 04:36:16 +0200 (CEST)
Received: from rms by fencepost.gnu.org with local (Exim 4.10)
	id 199FTq-0003aR-00; Fri, 25 Apr 2003 22:31:58 -0400
From: Richard Stallman <rms@gnu.org>
To: Hartmut Pilch <phm@a2e.de>
Cc: seth.johnson@RealMeasures.dyndns.org,
	C-FIT_Community@RealMeasures.dyndns.org,
	C-FIT_Release_Community@RealMeasures.dyndns.org,
	fairuse-discuss@nyfairuse.org, DMCA_Discuss@lists.microshaft.org,
	patents@aful.org, fos-forum@topica.com
In-reply-to: <Pine.LNX.4.44.0304241850520.8320-100000@querty.oas.a2e.de>
	(message from Hartmut Pilch on Thu, 24 Apr 2003 19:08:01 +0200 (CEST))
Subject: Re: [Patents] Article Defending Bayh-Dole
Reply-To: rms@gnu.org
References:  <Pine.LNX.4.44.0304241850520.8320-100000@querty.oas.a2e.de>
Message-Id: <E199FTq-0003aR-00@fencepost.gnu.org>
Date: Fri, 25 Apr 2003 22:31:58 -0400
X-Validation-by: rms@gnu.org

Pharmaceuticals are a very unusual field, since governments require
expensive tests to get permission to sell a drug.  Arguments based on
this situation have no relevance to other fields.

